Increased Expression of AXL and c‐MET in High‐Grade Clear Cell Renal Cell Carcinoma and Its Association With VEGFR‐TKI Treatment and PD‐L1 Expression

Ähnliche Einträge

• Volumetric imaging of the tumor microvasculature reflects outcomes and genomic states of clear cell renal cell carcinoma
  von: Yuta Kaneko, et al.
  Veröffentlicht: (2024)
• Kidney Injury Molecule‐1 Expression in Pathological T1b Clear Cell Renal Cell Carcinoma: A Putative Biomarker of High Immune‐Inflamed Status and Recurrence
  von: Ayuna Sugai, et al.
  Veröffentlicht: (2025)
• Prognostically Significant Glycan Profiles of Clear Cell Renal Cell Carcinoma Identified by Integrated Glycome–Methylome Analysis
  von: Yoshiko Kitazume, et al.
  Veröffentlicht: (2025)
• Comparison of Histologic Parameters and Predictive Gene Signatures in Clear Cell Renal Cell Carcinoma Response to Systemic Therapy
  von: Chisato Ohe, et al.
  Veröffentlicht: (2025)
• Immunoreactivities of ZCCHC3 and Efp in the High‐Grade Serous and Clear Cell Ovarian Carcinomas Are Worse Prognostic Factors
  von: Erina Iwabuchi, et al.
  Veröffentlicht: (2026)